PURPOSE: Neurosurgery is an effective therapy for selected individuals with medically refractory temporal lobe epilepsy (TLE). De novo psychopathology may complicate the postsurgical outcome. Our aims were to identify predictors of de novo psychiatric and seizure outcome following TLE surgery. METHODS: Medical records of 280 patients who underwent TLE surgery were reviewed. Preoperative and postoperative psychiatric diagnoses were identified, in addition to information on seizure recurrence and neuropsychological status. Logistic regression analysis was used to identify predictors of having a de novo psychiatric diagnosis and remaining seizure-free within 4 years following surgery. KEY FINDINGS: One hundred five patients (38%) had significant psychiatric problems within 4 years following TLE surgery. Fifty-one patients (18%) developed de novo psychopathology; half of cases presented within 6 months and 90% of psychopathologies persisted 6 months or longer. A preoperative history of secondary generalized tonic-clonic seizure(s) (SGTCS) was an independent predictor of de novo psychopathology (odds ratio [OR] 2.73, 95% confidence interval [CI] 1.14-6.59, p = 0.02). From patients with available seizure data, 49% (127 of 258) remained seizure-free for 4 years after surgery. Patients with a history of SGTCS (OR 0.47, 95% CI 0.25-0.90, p = 0.02) and those with a preoperative psychiatric diagnosis (OR 0.53, 95% CI 0.28-0.98, p = 0.04) were significantly less likely to remain seizure-free. SIGNIFICANCE: De novo psychopathology is a significant complication of TLE surgery. Inclusion of neuropsychiatric assessments in the presurgical evaluation may lead to increase in the power of prognostic models used to predict the neurologic outcome of TLE surgery. Wiley Periodicals, Inc.
PURPOSE: Neurosurgery is an effective therapy for selected individuals with medically refractory temporal lobe epilepsy (TLE). De novo psychopathology may complicate the postsurgical outcome. Our aims were to identify predictors of de novo psychiatric and seizure outcome following TLE surgery. METHODS: Medical records of 280 patients who underwent TLE surgery were reviewed. Preoperative and postoperative psychiatric diagnoses were identified, in addition to information on seizure recurrence and neuropsychological status. Logistic regression analysis was used to identify predictors of having a de novo psychiatric diagnosis and remaining seizure-free within 4 years following surgery. KEY FINDINGS: One hundred five patients (38%) had significant psychiatric problems within 4 years following TLE surgery. Fifty-one patients (18%) developed de novo psychopathology; half of cases presented within 6 months and 90% of psychopathologies persisted 6 months or longer. A preoperative history of secondary generalized tonic-clonic seizure(s) (SGTCS) was an independent predictor of de novo psychopathology (odds ratio [OR] 2.73, 95% confidence interval [CI] 1.14-6.59, p = 0.02). From patients with available seizure data, 49% (127 of 258) remained seizure-free for 4 years after surgery. Patients with a history of SGTCS (OR 0.47, 95% CI 0.25-0.90, p = 0.02) and those with a preoperative psychiatric diagnosis (OR 0.53, 95% CI 0.28-0.98, p = 0.04) were significantly less likely to remain seizure-free. SIGNIFICANCE: De novo psychopathology is a significant complication of TLE surgery. Inclusion of neuropsychiatric assessments in the presurgical evaluation may lead to increase in the power of prognostic models used to predict the neurologic outcome of TLE surgery. Wiley Periodicals, Inc.
Authors: Siobhan West; Sarah J Nevitt; Jennifer Cotton; Sacha Gandhi; Jennifer Weston; Ajay Sudan; Roberto Ramirez; Richard Newton Journal: Cochrane Database Syst Rev Date: 2019-06-25
Authors: Marian Galovic; Irene Baudracco; Evan Wright-Goff; Galo Pillajo; Parashkev Nachev; Britta Wandschneider; Friedrich Woermann; Pamela Thompson; Sallie Baxendale; Andrew W McEvoy; Mark Nowell; Matteo Mancini; Sjoerd B Vos; Gavin P Winston; Rachel Sparks; Ferran Prados; Anna Miserocchi; Jane de Tisi; Louis André Van Graan; Roman Rodionov; Chengyuan Wu; Mahdi Alizadeh; Lauren Kozlowski; Ashwini D Sharan; Lohith G Kini; Kathryn A Davis; Brian Litt; Sebastien Ourselin; Solomon L Moshé; Josemir W A Sander; Wolfgang Löscher; John S Duncan; Matthias J Koepp Journal: JAMA Neurol Date: 2019-06-01 Impact factor: 18.302
Authors: Katherine W Scangos; Hasan S Ahmad; Alia Shafi; Kristin K Sellers; Heather E Dawes; Andrew Krystal; Edward F Chang Journal: J Neuropsychiatry Clin Neurosci Date: 2019-08-09 Impact factor: 2.198
Authors: Christine Doherty; Amy S Nowacki; Mary Pat McAndrews; Carrie R McDonald; Anny Reyes; Michelle S Kim; Marla Hamberger; Imad Najm; William Bingaman; Lara Jehi; Robyn M Busch Journal: Epilepsia Date: 2021-01-19 Impact factor: 6.740